10 results
8-K
EX-99.1
PROK
ProKidney Corp.
11 Sep 23
Regulation FD Disclosure
8:01am
, reimbursement and value-based pricing (REGEN-016 & REGEN-008) 006 1st Registrational 016 2nd Registrational 015 Repeat dosing & Product Lifecycle 003 Label
424B3
PROK
ProKidney Corp.
9 Sep 22
Prospectus supplement
5:05pm
June 2007. Most recently, Dr. McKenzie served as Vice President, Medical, Global Head of Lifecycle Safety Project Leadership and Strategic Solutions from
DEFA14A
PROK
ProKidney Corp.
28 Apr 22
Additional proxy soliciting materials
4:33pm
of increasing responsibility since 2007. Most recently, she served as Vice President, Medical, Global Head of Lifecycle Safety Project Leadership
424B4
uwke49f7wfhm3n5
1 Jul 21
Prospectus supplement with pricing info
5:20pm
S-1
pgselj g2egru02uah4
2 Jun 21
IPO registration
5:17pm
DRS
y1v0 7xsxzy3v1t1
21 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next